Percutaneous Sclerotherapy of Venous Malformations.


Journal

Techniques in vascular and interventional radiology
ISSN: 1557-9808
Titre abrégé: Tech Vasc Interv Radiol
Pays: United States
ID NLM: 9806675

Informations de publication

Date de publication:
Jun 2024
Historique:
medline: 22 8 2024
pubmed: 22 8 2024
entrez: 21 8 2024
Statut: ppublish

Résumé

Venous malformation (VM) stands as the most prevalent form of vascular malformation, characterized by its diverse morphology. These lesions can manifest in any part of the body, affecting different tissue planes and giving rise to symptoms such as pain, swelling, or physical dysfunction. In the realm of treatment, direct puncture VM sclerotherapy holds its place as the primary approach. This technique involves the administration of a sclerosing agent into the VM channels during contrast phlebography while simultaneously managing the outflow veins through different methods. The process of VM sclerotherapy induces endothelial damage, thrombosis, and fibrosis, resulting in symptom relief through lesion shrinkage. It is crucial to exercise caution techniques and sclerosing agents during VM sclerotherapy to minimize procedural complications, enhance clinical outcomes, and ultimately improve the patient's overall quality of life.

Identifiants

pubmed: 39168545
pii: S1089-2516(24)00016-7
doi: 10.1016/j.tvir.2024.100960
pii:
doi:

Substances chimiques

Sclerosing Solutions 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100960

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Kyung Rae Kim (KR)

Boston Children's Hospital, Harvard Medical School, Department of Radiology, Division of Pediatric Interventional Radiology, University of North Carolina at Chapel Hill, School of Medicine, Boston, MA; Department of Radiology, Division of Vascular and Interventional Radiology, University of North Carolina Medical Center, Boston, MA. Electronic address: kyung.kim@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH